Adaptyv Biosystems

Adaptyv Biosystems
Automated wet lab for AI-driven protein design, enabling rapid synthesis, expression, and testing of thousands of protein designs.
About
What does Adaptyv Biosystems do?
Adaptyv Bio provides an automated lab service for agentic biology, enabling rapid protein validation from sequence design to experimental data in under three weeks. Their all-in-one platform allows users to upload protein designs, choose data types, and receive high-quality experimental results, purpose-built for AI-first protein engineering. They serve leading protein design teams by delivering clean, experimental data to train and improve AI models.
Is Adaptyv Biosystems trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Adaptyv Biosystems is 82 out of 100, based on site security posture and privacy practices.
What is Adaptyv Biosystems's revenue?
StartupHub estimates Adaptyv Biosystems's annual revenue at $2.3M (range $1.3M to $5.3M, 67% confidence), based on comparable companies in the sector.
What is Adaptyv Biosystems's valuation?
StartupHub estimates Adaptyv Biosystems's effective valuation at $156.0M (range $100.0M to $240.0M, 24% confidence), based on comparable companies in the sector.
How much funding has Adaptyv Biosystems raised?
Adaptyv Biosystems has raised a total of $40M in funding. The most recent round on record is Series A.
Where is Adaptyv Biosystems headquartered?
Adaptyv Biosystems is headquartered in Lausanne, Switzerland.
When was Adaptyv Biosystems founded?
Adaptyv Biosystems was founded in 2021.
What industry does Adaptyv Biosystems operate in?
Adaptyv Biosystems operates in Biotechnology, Artificial Intelligence, Drug Discovery, Life Sciences, Biotech, AI-Driven Protein Design.
How many employees does Adaptyv Biosystems have?
Adaptyv Biosystems has approximately 25 people on record.
Galatek develops AI-driven automation solutions for life sciences laboratories and advanced semiconductor manufacturing, focusing on precision and reproducibility.
Digital batch record software for pharmaceutical and biotech manufacturing.
Develops and commercializes treatments for central nervous system disorders, including Rett syndrome.
An entrant is a company tagged Biotechnology whose domain was first registered in the window, counted from registry records in the StartupHub directory. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.

